Pesquisar
Indivior PLC
INDVAdicionar à lista de desejos
34.220USD
-0.250-0.73%
Fechamento 09-15 16:00（ET）
4.04BValor de mercado
20.38P/L TTM
Mais detalhes de Indivior PLC Empresa
Indivior PLC is a global pharmaceutical company engaged in developing medicines to treat substance-use disorders (SUD). The Company provides treatment for addiction, including SUBLOCADE (buprenorphine extended-release) injection for subcutaneous use, a long-acting injectable (LAI) for opioid use disorder and OPVEE (Nalmefene) nasal spray for opioid overdose recovery. Its core products include SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, OPVEE (nalmefene), and SUBLOCADE. SUBOXONE Film is a buprenorphine and naloxone sublingual film. SUBOXONE Tablet is a buprenorphine and naloxone sublingual tablet. SUBUTEX Tablet is a buprenorphine sublingual tablet. SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, and SUBLOCADE are treatments for opioid use disorder (OUD). In addition to its commercially available products, its product pipeline includes two drug candidates for the treatment of OUD. The Company sells its products in the United States and in other selected areas of the world.
Indivior PLC Perfil
Código da empresaINDV
Nome da EmpresaIndivior PLC
Data de listagemDec 24, 2014
CEOCiaffoni (Joseph J)
Número de funcionários1030
Tipo de títulosOrdinary Share
Fim do ano fiscalDec 24
Endereço234 Bath Road
CidadeSLOUGH
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited Kingdom
Código postalSL1 4EE
Telefone448043791090
Sitehttps://www.indivior.com/en
Código da empresaINDV
Data de listagemDec 24, 2014
CEOCiaffoni (Joseph J)
Executivos da empresa Indivior PLC
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Joseph J. (Joe) Ciaffoni
Mr. Joseph J. (Joe) Ciaffoni
Chief Executive Officer, Director
Chief Executive Officer, Director
710.35K
--
Mr. Christian Heidbreder
Mr. Christian Heidbreder
Chief Scientific Officer
Chief Scientific Officer
175.72K
--
Mr. Vishal Kalia
Mr. Vishal Kalia
Chief Impact and Strategy Officer
Chief Impact and Strategy Officer
137.46K
+3.15%
Mr. Jeffrey W. (Jeff) Burris, Esq., J.D.
Mr. Jeffrey W. (Jeff) Burris, Esq., J.D.
Chief Legal Officer
Chief Legal Officer
44.62K
--
Mr. Patrick A. Barry
Mr. Patrick A. Barry
Chief Commercial Officer
Chief Commercial Officer
31.38K
--
Mr. Daniel A. (Dan) Ninivaggi, J.D.
Mr. Daniel A. (Dan) Ninivaggi, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
20.64K
--
Ms. Juliet Thompson
Ms. Juliet Thompson
Senior Non-Executive Independent Director
Senior Non-Executive Independent Director
12.23K
--
Dr. Keith Humphreys
Dr. Keith Humphreys
Non-Executive Independent Director
Non-Executive Independent Director
9.52K
--
,
,
--
--
Ms. Kathryn Barbara Hudson
Ms. Kathryn Barbara Hudson
Company Secretary
Company Secretary
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Joseph J. (Joe) Ciaffoni
Mr. Joseph J. (Joe) Ciaffoni
Chief Executive Officer, Director
Chief Executive Officer, Director
710.35K
--
Mr. Christian Heidbreder
Mr. Christian Heidbreder
Chief Scientific Officer
Chief Scientific Officer
175.72K
--
Mr. Vishal Kalia
Mr. Vishal Kalia
Chief Impact and Strategy Officer
Chief Impact and Strategy Officer
137.46K
+3.15%
Mr. Jeffrey W. (Jeff) Burris, Esq., J.D.
Mr. Jeffrey W. (Jeff) Burris, Esq., J.D.
Chief Legal Officer
Chief Legal Officer
44.62K
--
Mr. Patrick A. Barry
Mr. Patrick A. Barry
Chief Commercial Officer
Chief Commercial Officer
31.38K
--
Mr. Daniel A. (Dan) Ninivaggi, J.D.
Mr. Daniel A. (Dan) Ninivaggi, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
20.64K
--
Perguntas frequentes
Quem são os cinco principais acionistas de Indivior PLC?
Os cinco principais acionistas de Indivior PLC são: Mr. Joseph J. (Joe) Ciaffoni
Quantas instituições possuem ações da Indivior PLC (INDV)?
Em 2026Q1, 516 instituições possuíam ações da Indivior PLC, com valor de mercado aproximado de 123.98M, representando 102.46% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -10661085.00.